tailieunhanh - báo cáo khoa học: " Closing the access gap for health innovations: an open licensing proposal for universities"

Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Closing the access gap for health innovations: an open licensing proposal for universities | Globalization and Health BioMed Central Open Access Debate Closing the access gap for health innovations an open licensing proposal for universities Samantha Chaifetz1 Dave A Chokshi 2 Rahul Rajkumar1 David Scales1 and Yochai Benkler1 Address Yale University New Haven CT USA and 2University of Pennsylvania Philadelphia PA USA Email Samantha Chaifetz - Dave A Chokshi - daveash@ Rahul Rajkumar - David Scales - Yochai Benkler - Corresponding author Published I February 2007 Globalization and Health 2007 3 I doi I744-8603-3-I Received 5 September 2006 Accepted I February 2007 This article is available from http content 3 I I 2007 Chaifetz et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract__ Background This article centers around a proposal outlining how research universities could leverage their intellectual property to help close the access gap for health innovations in poor countries. A recent deal between Emory University Gilead Sciences and Royalty Pharma is used as an example to illustrate how equitable access licensing could be put into practice. Discussion While the crisis of access to medicines in poor countries has multiple determinants intellectual property protection leading to high prices is well-established as one critical element of the access gap. Given the current international political climate systemic government-driven reform of intellectual property protection seems unlikely in the near term. Therefore we propose that public sector institutions universities chief .